Related Experiment Video
Updated: May 12, 2026
11:12
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
Published on: August 1, 2018
Classification of breast carcinomas according to gene expression profiles
L Moldovan1, A Mitroi, C M Petrescu
1Clinical Studies Department, Panduri Hospital of Bucharest, Bucharest, Romania. geamai_ayfer@yahoo.com
Journal of Medicine and Life
|April 20, 2013
Summary
Gene expression profiling using DNA microarrays helps classify breast cancer subtypes and predict patient outcomes. This technology offers a molecular complement to traditional methods for diagnosis and prognosis.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Breast carcinoma is a significant health concern with limited understanding of its molecular progression.
- Accurate diagnosis, prognosis, and treatment rely on understanding molecular events in cancer development.
Purpose of the Study:
- To review recent DNA microarray studies on gene expression profiling in breast carcinomas.
- To highlight the use of microarrays in classifying tumors and identifying prognostic markers.
Main Methods:
- Gene expression microarray technology was employed to analyze breast carcinoma specimens.
- Tumor samples were profiled to identify molecular properties and gene expression patterns.
Main Results:
- Gene expression profiles can distinguish cell type-specific clusters (stromal, epithelial, mesenchymal, proliferation).
- Breast tumors are classified into subtypes: basal-like, luminal-like, ERBB2 overexpressing, and normal breast-like.
- Prognostic profiles associated with good and poor outcomes in young, node-negative patients were identified.
Conclusions:
- DNA microarray technology is a powerful tool for breast cancer diagnosis and prognosis.
- Gene expression profiling provides molecular insights complementing histopathology and immunohistochemistry.
- This approach enhances the understanding of breast cancer heterogeneity and clinical outcome prediction.
Related Concept Videos
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...